Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.40 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.40 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.37 |
| ▸ | KIF11 | P52732 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 2/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | HTR1D | P28221 | 3/20 | 0.35 |
| ▸ | DAO | P14920 | 1/20 | 0.35 |
| ▸ | PDE2A | O00408 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18701033 | 0.86 | CYP1A2 (0.43) | IDO1CYP1A2CYP2C19EPHX2NR1H4 | |
| SCHEMBL20820505 | 0.83 | EPHX2 (0.42) | IDO1CYP1A2CYP2C19EPHX2NR1H4 | |
| SCHEMBL19841845 | 0.80 | KCNH2 (0.39) | IDO1CYP1A2CYP2C19EPHX2NR1H4 | |
| SCHEMBL10162939 | 0.80 | EPHX2 (0.45) | IDO1CYP1A2CYP2C19EPHX2NR1H4 | |
| SCHEMBL13073947 | 0.79 | CYP1A2 (0.41) | CYP1A2CYP2C19KIF11ALDH1A1HPGD | |
| SCHEMBL21376383 | 0.79 | TAAR1 (0.40) | IDO1CYP1A2CYP2C19EPHX2NR1H4 | |
| SCHEMBL14297625 | 0.78 | EPHX2 (0.44) | IDO1CYP1A2CYP2C19EPHX2NR1H4 | |
| SCHEMBL6644304 | 0.78 | PON1 (0.45) | IDO1CYP1A2CYP2C19EPHX2NR1H4 | |
| SCHEMBL13619369 | 0.78 | IDO1 (0.43) | IDO1CYP1A2CYP2C19EPHX2NR1H4 | |
| SCHEMBL21184908 | 0.77 | CYP1A2 (0.34) | IDO1CYP1A2CYP2C19EPHX2NR1H4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090264417-A1 | SULFONYL-SUBSTITUTED BICYCLIC COMPOUNDS AS MODULATORS OF PPAR | KALYPSYS, INC. (US) | 2009-10-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090264417-A1 | SULFONYL-SUBSTITUTED BICYCLIC COMPOUNDS AS MODULATORS OF PPAR | PPARG, PPARA, PPARD | IDO1 3838/4885CYP1A2 1800/4885CYP2C19 1560/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.